Product Description

ILF2 Polyclonal Antibody

Catalogue Numbers: BS67511-50, BS67511-100

Sizes: 50µl, 100µl

Product: Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide.

Swiss-Prot: Q12905

Host: Rabbit

Reactivity: Human, Mouse, Rat

Applications: WB

All Applications: WB (1/500 - 1/1000)

Background: Chromatin-interacting protein that forms a stable heterodimer with interleukin enhancer-binding factor 3/ILF3 and plays a role in several biological processes including transcription, innate immunity or cell growth.Essential for the efficient reshuttling of ILF3 (isoform 1 and isoform 2) into the nucleus. Together with ILF3, forms an RNA-binding complex that is required for mitotic progression and cytokinesis by regulating the expression of a cluster of mitotic genes. Mechanistically, competes with STAU1/STAU2-mediated mRNA decay.Also plays a role in the inhibition of various viruses including Japanese encephalitis virus or enterovirus 717 Publications(Microbial infection) Plays a positive role in HIV-1 virus production by binding to and thereby stabilizing HIV-1 RNA, together with ILF3.

Purification and Purity: The antibody was purified by immunogen affinity chromatography.

Storage and Stability: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

Specificity: Recognizes endogenous levels of ILF2 protein.

Extra Notes: Western blot analysis of ILF2 expression in Raw264.7 (A), Beas2B (B), HCT116 (C), HEK293T (D) whole cell lysates.

Bioworld Molecular Weight: ~ 43 kDa

Note: For research use only, not for use in diagnostic procedure.

Alternative Name: NF45; Interleukin enhancer-binding factor 2; Nuclear factor of activated T-cells 45 kDa

Immunogen: KLH-conjugated synthetic peptide encompassing a sequence within the C-term region of human ILF2. The exact sequence is proprietary.

Conjugate: Unconjugated

Modification: Unmodified